1. Home
  2. FUL vs QURE Comparison

FUL vs QURE Comparison

Compare FUL & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo H. B. Fuller Company

FUL

H. B. Fuller Company

N/A

Current Price

$50.10

Market Cap

2.7B

Sector

Industrials

ML Signal

N/A

Logo uniQure N.V.

QURE

uniQure N.V.

N/A

Current Price

$23.38

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FUL
QURE
Founded
1887
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.1B
IPO Year
2008
2013

Fundamental Metrics

Financial Performance
Metric
FUL
QURE
Price
$50.10
$23.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
12
Target Price
★ $68.29
$68.25
AVG Volume (30 Days)
741.0K
★ 1.9M
Earning Date
09-23-2026
11-09-2026
Dividend Yield
★ 1.98%
N/A
EPS Growth
19.57
★ 29.67
EPS
★ 3.05
N/A
Revenue
★ $2,897,000,000.00
$13,107,000.00
Revenue This Year
$3.87
$55.91
Revenue Next Year
$7.46
$356.42
P/E Ratio
$16.28
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$46.70
$8.73
52 Week High
$68.63
$71.50

Technical Indicators

Market Signals
Indicator
FUL
QURE
Relative Strength Index (RSI) 29.52 19.51
Support Level $46.70 $21.91
Resistance Level $65.67 $27.66
Average True Range (ATR) 1.67 2.13
MACD 0.08 -2.26
Stochastic Oscillator 28.61 10.03

Price Performance

Historical Comparison
FUL
QURE

About FUL H. B. Fuller Company

H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. It generates the maximum revenue from hygiene, health, and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven, and hygiene (disposable diapers, feminine care, and medical garments) and health and beauty. The company generates around half of its revenue in the United States.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: